SMTL ID : 9k75.1

SARS-CoV-2 related bat coronavirus BANAL-103 spike in the closed state

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

homo-trimer

Ligands

60 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 2 residues within 4Å: Chain A: N.112, Q.134 Ligand excluded by PLIP NAG.2: 5 residues within 4Å: Chain A: N.122, A.123, T.124, I.127, E.155 Ligand excluded by PLIP NAG.3: 2 residues within 4Å: Chain A: E.277, N.278 Ligand excluded by PLIP NAG.4: 2 residues within 4Å: Chain A: N.612, T.614 Ligand excluded by PLIP NAG.5: 1 residues within 4Å: Chain A: N.599 Ligand excluded by PLIP NAG.6: 3 residues within 4Å: Chain A: N.701 Chain B: I.786, D.788 Ligand excluded by PLIP NAG.7: 3 residues within 4Å: Chain A: C.16, N.18, Y.137 Ligand excluded by PLIP NAG.8: 2 residues within 4Å: Chain A: F.29, N.62 Ligand excluded by PLIP NAG.9: 3 residues within 4Å: Chain A: N.164 Chain C: Y.347, I.464 Ligand excluded by PLIP NAG.10: 2 residues within 4Å: Chain A: N.31, Y.60 Ligand excluded by PLIP NAG.11: 2 residues within 4Å: Chain A: A.698, N.1066 Ligand excluded by PLIP NAG.12: 3 residues within 4Å: Chain A: N.793, S.795, Q.796 Ligand excluded by PLIP NAG.13: 2 residues within 4Å: Chain A: N.327, Q.576 Ligand excluded by PLIP NAG.14: 4 residues within 4Å: Chain A: N.366 Chain C: F.452, Y.485, Q.489 Ligand excluded by PLIP NAG.15: 1 residues within 4Å: Chain A: N.653 Ligand excluded by PLIP NAG.16: 2 residues within 4Å: Chain A: N.709, Q.1063 Ligand excluded by PLIP NAG.17: 2 residues within 4Å: Chain A: N.1090, T.1092 Ligand excluded by PLIP NAG.18: 1 residues within 4Å: Chain A: N.1126 Ligand excluded by PLIP NAG.19: 8 residues within 4Å: Chain A: T.108, N.233, T.235 Chain C: R.453, S.455, N.456, K.458, E.461 Ligand excluded by PLIP NAG.20: 1 residues within 4Å: Chain A: N.339 Ligand excluded by PLIP NAG.21: 2 residues within 4Å: Chain B: N.112, Q.134 Ligand excluded by PLIP NAG.22: 5 residues within 4Å: Chain B: N.122, A.123, T.124, I.127, E.155 Ligand excluded by PLIP NAG.23: 2 residues within 4Å: Chain B: E.277, N.278 Ligand excluded by PLIP NAG.24: 2 residues within 4Å: Chain B: N.612, T.614 Ligand excluded by PLIP NAG.25: 1 residues within 4Å: Chain B: N.599 Ligand excluded by PLIP NAG.26: 3 residues within 4Å: Chain B: N.701 Chain C: I.786, D.788 Ligand excluded by PLIP NAG.27: 3 residues within 4Å: Chain B: C.16, N.18, Y.137 Ligand excluded by PLIP NAG.28: 2 residues within 4Å: Chain B: F.29, N.62 Ligand excluded by PLIP NAG.29: 3 residues within 4Å: Chain A: Y.347, I.464 Chain B: N.164 Ligand excluded by PLIP NAG.30: 2 residues within 4Å: Chain B: N.31, Y.60 Ligand excluded by PLIP NAG.31: 2 residues within 4Å: Chain B: A.698, N.1066 Ligand excluded by PLIP NAG.32: 3 residues within 4Å: Chain B: N.793, S.795, Q.796 Ligand excluded by PLIP NAG.33: 2 residues within 4Å: Chain B: N.327, Q.576 Ligand excluded by PLIP NAG.34: 4 residues within 4Å: Chain A: F.452, Y.485, Q.489 Chain B: N.366 Ligand excluded by PLIP NAG.35: 1 residues within 4Å: Chain B: N.653 Ligand excluded by PLIP NAG.36: 2 residues within 4Å: Chain B: N.709, Q.1063 Ligand excluded by PLIP NAG.37: 2 residues within 4Å: Chain B: N.1090, T.1092 Ligand excluded by PLIP NAG.38: 1 residues within 4Å: Chain B: N.1126 Ligand excluded by PLIP NAG.39: 8 residues within 4Å: Chain A: R.453, S.455, N.456, K.458, E.461 Chain B: T.108, N.233, T.235 Ligand excluded by PLIP NAG.40: 1 residues within 4Å: Chain B: N.339 Ligand excluded by PLIP NAG.41: 2 residues within 4Å: Chain C: N.112, Q.134 Ligand excluded by PLIP NAG.42: 5 residues within 4Å: Chain C: N.122, A.123, T.124, I.127, E.155 Ligand excluded by PLIP NAG.43: 2 residues within 4Å: Chain C: E.277, N.278 Ligand excluded by PLIP NAG.44: 2 residues within 4Å: Chain C: N.612, T.614 Ligand excluded by PLIP NAG.45: 1 residues within 4Å: Chain C: N.599 Ligand excluded by PLIP NAG.46: 3 residues within 4Å: Chain A: I.786, D.788 Chain C: N.701 Ligand excluded by PLIP NAG.47: 3 residues within 4Å: Chain C: C.16, N.18, Y.137 Ligand excluded by PLIP NAG.48: 2 residues within 4Å: Chain C: F.29, N.62 Ligand excluded by PLIP NAG.49: 3 residues within 4Å: Chain B: Y.347, I.464 Chain C: N.164 Ligand excluded by PLIP NAG.50: 2 residues within 4Å: Chain C: N.31, Y.60 Ligand excluded by PLIP NAG.51: 2 residues within 4Å: Chain C: A.698, N.1066 Ligand excluded by PLIP NAG.52: 3 residues within 4Å: Chain C: N.793, S.795, Q.796 Ligand excluded by PLIP NAG.53: 2 residues within 4Å: Chain C: N.327, Q.576 Ligand excluded by PLIP NAG.54: 4 residues within 4Å: Chain B: F.452, Y.485, Q.489 Chain C: N.366 Ligand excluded by PLIP NAG.55: 1 residues within 4Å: Chain C: N.653 Ligand excluded by PLIP NAG.56: 2 residues within 4Å: Chain C: N.709, Q.1063 Ligand excluded by PLIP NAG.57: 2 residues within 4Å: Chain C: N.1090, T.1092 Ligand excluded by PLIP NAG.58: 1 residues within 4Å: Chain C: N.1126 Ligand excluded by PLIP NAG.59: 8 residues within 4Å: Chain B: R.453, S.455, N.456, K.458, E.461 Chain C: T.108, N.233, T.235 Ligand excluded by PLIP NAG.60: 1 residues within 4Å: Chain C: N.339 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Li, Q. et al., Structural and functional constraints on spike activation and host protease utilization limit cell entry of SARS-CoV-2-related bat coronaviruses. J.Virol. (2025)

Release Date

2025-07-16

Peptides

Spike glycoprotein: ABC

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

Spike glycoprotein